MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example Regimen Definition: ddAC→T (Dose-Dense AC then Paclitaxel)

Page standards status: Informative

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/PlanDefinition/RegimenDdACT> a fhir:PlanDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:Resource.id [ fhir:value "RegimenDdACT"] ;
  fhir:Resource.meta [
     fhir:Meta.profile [
       fhir:value "http://hl7.org/fhir/us/codex-mopa/StructureDefinition/anticancer-regimen-plandefinition" ;
       fhir:index -1 ;
       fhir:link <http://hl7.org/fhir/us/codex-mopa/StructureDefinition/anticancer-regimen-plandefinition>
     ]
  ] ;
  fhir:Resource.language [ fhir:value "en"] ;
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "extensions" ] ;
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n  <table class=\"narrative-table\">\n    <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">Metadata</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Version</th>\n\n\n\n<td class=\"content-container\">0.1.1-snapshot-080926</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Experimental</th>\n\n\n\n<td class=\"content-container\">true</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Subject Type</th>\n\n\n\n<td class=\"content-container\">\n    Malignant neoplasm of breast\n\n\n</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Jurisdiction</th>\n\n\n\n<td class=\"content-container\">\n    United States of America\n\n\n</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Interoperability Council</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward Contact</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Interoperability Council</td>\n\n\n</tr>\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\"><div><p>Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer.</p>\n</div></td>\n\n\n</tr>\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Type</th>\n\n\n\n<td class=\"content-container\">\n    Order Set\n\n\n</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">ac-phase</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">AC Phase — Doxorubicin + Cyclophosphamide (q14d × 4 cycles)</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Count 4  times, Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n  \n    \n      \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: ac-phase)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">doxorubicin-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">doxorubicin-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n  \n    \n      \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: ac-phase)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">pegfilgrastim-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Pegfilgrastim supportive care on day 2 of each ddAC cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">pegfilgrastim-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Pegfilgrastim supportive care on day 2 of each ddAC cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n  \n    \n      \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: ac-phase)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">cyclophosphamide-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">cyclophosphamide-ac</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n  \n\n\n\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">t-phase</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">T Phase — Paclitaxel (q14d × 4 cycles)</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Count 4  times, Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n  \n    \n      \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: t-phase)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">paclitaxel-t</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n      \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">paclitaxel-t</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Timing</th>\n\n\n\n<td class=\"content-container\">Once per 14 days</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n    \n  \n\n\n\n\n\n<tr>\n  <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.4 of the sample-content-ig Liquid templates</th>\n</tr>\n\n    </tbody>\n  </table>\n</div>"
  ] ;
  fhir:PlanDefinition.url [ fhir:value "http://hl7.org/fhir/us/codex-mopa/PlanDefinition/RegimenDdACT"] ;
  fhir:PlanDefinition.version [ fhir:value "0.1.1-snapshot-080926"] ;
  fhir:PlanDefinition.name [ fhir:value "RegimenDdACT"] ;
  fhir:PlanDefinition.title [ fhir:value "ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer"] ;
  fhir:PlanDefinition.type [
     fhir:CodeableConcept.coding [
       fhir:index -1 ;
       fhir:Coding.system [ fhir:value "http://terminology.hl7.org/CodeSystem/plan-definition-type" ] ;
       fhir:Coding.code [ fhir:value "order-set" ] ;
       fhir:Coding.display [ fhir:value "Order Set" ]
     ]
  ] ;
  fhir:PlanDefinition.status [ fhir:value "active"] ;
  fhir:PlanDefinition.experimental [ fhir:value "true"^^xsd:boolean] ;
  fhir:PlanDefinition.subjectCodeableConcept [
     fhir:CodeableConcept.coding [
       fhir:index -1 ;
       a sct:254837009 ;
       fhir:Coding.system [ fhir:value "http://snomed.info/sct" ] ;
       fhir:Coding.code [ fhir:value "254837009" ] ;
       fhir:Coding.display [ fhir:value "Malignant neoplasm of breast" ]
     ]
  ] ;
  fhir:PlanDefinition.date [ fhir:value "2026-09-08T18:17:28-04:00"^^xsd:dateTime] ;
  fhir:PlanDefinition.publisher [ fhir:value "HL7 International / Clinical Interoperability Council"] ;
  fhir:PlanDefinition.contact [
     fhir:index -1 ;
     fhir:ContactDetail.name [ fhir:value "HL7 International / Clinical Interoperability Council" ] ;
     fhir:ContactDetail.telecom [
       fhir:index -1 ;
       fhir:ContactPoint.system [ fhir:value "url" ] ;
       fhir:ContactPoint.value [ fhir:value "http://www.hl7.org/Special/committees/cic" ]
     ], [
       fhir:index -1 ;
       fhir:ContactPoint.system [ fhir:value "email" ] ;
       fhir:ContactPoint.value [ fhir:value "ciclist@lists.HL7.org" ]
     ]
  ] ;
  fhir:PlanDefinition.description [ fhir:value "Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer."] ;
  fhir:PlanDefinition.jurisdiction [
     fhir:index -1 ;
     fhir:CodeableConcept.coding [
       fhir:index -1 ;
       fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ] ;
       fhir:Coding.code [ fhir:value "US" ] ;
       fhir:Coding.display [ fhir:value "United States of America" ]
     ]
  ] ;
  fhir:PlanDefinition.action [
     fhir:index -1 ;
     fhir:Element.id [ fhir:value "ac-phase" ] ;
     fhir:PlanDefinition.action.title [ fhir:value "AC Phase — Doxorubicin + Cyclophosphamide (q14d × 4 cycles)" ] ;
     fhir:PlanDefinition.action.timingTiming [
       fhir:Timing.repeat [
         fhir:Timing.repeat.count [ fhir:value "4"^^xsd:positiveInteger ] ;
         fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
         fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
       ]
     ] ;
     fhir:PlanDefinition.action.action [
       fhir:index -1 ;
       fhir:Element.id [ fhir:value "doxorubicin-ac" ] ;
       fhir:PlanDefinition.action.title [ fhir:value "Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle" ] ;
       fhir:PlanDefinition.action.timingTiming [
         fhir:Timing.repeat [
           fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
           fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
         ]
       ]
     ], [
       fhir:index -1 ;
       fhir:Element.id [ fhir:value "pegfilgrastim-ac" ] ;
       fhir:PlanDefinition.action.title [ fhir:value "Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle" ] ;
       fhir:PlanDefinition.action.description [ fhir:value "Pegfilgrastim supportive care on day 2 of each ddAC cycle" ] ;
       fhir:PlanDefinition.action.timingTiming [
         fhir:Element.extension [
           fhir:index -1 ;
           fhir:Element.extension [
             fhir:index -1 ;
             fhir:Extension.url [ fhir:value "day" ] ;
             fhir:Extension.valueInteger [ fhir:value "2"^^xsd:integer ]
           ] ;
           fhir:Extension.url [ fhir:value "http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle" ]
         ] ;
         fhir:Timing.repeat [
           fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
           fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
         ]
       ]
     ], [
       fhir:index -1 ;
       fhir:Element.id [ fhir:value "cyclophosphamide-ac" ] ;
       fhir:PlanDefinition.action.title [ fhir:value "Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle" ] ;
       fhir:PlanDefinition.action.timingTiming [
         fhir:Timing.repeat [
           fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
           fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
         ]
       ]
     ]
  ], [
     fhir:index -1 ;
     fhir:Element.id [ fhir:value "t-phase" ] ;
     fhir:PlanDefinition.action.title [ fhir:value "T Phase — Paclitaxel (q14d × 4 cycles)" ] ;
     fhir:PlanDefinition.action.relatedAction [
       fhir:index -1 ;
       fhir:PlanDefinition.action.relatedAction.actionId [ fhir:value "ac-phase" ] ;
       fhir:PlanDefinition.action.relatedAction.relationship [ fhir:value "after-end" ]
     ] ;
     fhir:PlanDefinition.action.timingTiming [
       fhir:Timing.repeat [
         fhir:Timing.repeat.count [ fhir:value "4"^^xsd:positiveInteger ] ;
         fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
         fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
       ]
     ] ;
     fhir:PlanDefinition.action.action [
       fhir:index -1 ;
       fhir:Element.id [ fhir:value "paclitaxel-t" ] ;
       fhir:PlanDefinition.action.title [ fhir:value "Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle" ] ;
       fhir:PlanDefinition.action.timingTiming [
         fhir:Timing.repeat [
           fhir:Timing.repeat.period [ fhir:value "14"^^xsd:decimal ] ;
           fhir:Timing.repeat.periodUnit [ fhir:value "d" ]
         ]
       ]
     ]
  ] .

# - ontology header ------------------------------------------------------------

<http://hl7.org/fhir/PlanDefinition/RegimenDdACT.ttl> a owl:Ontology ;
  owl:imports fhir:fhir.ttl ;
  owl:versionIRI <http://build.fhir.org/PlanDefinition/RegimenDdACT.ttl> .